Ikarian Capital »

Cumberland Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cumberland Pharmaceuticals (CPIX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cumberland Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cumberland Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cumberland Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 556k 3.12
2025-06-30 $2.0M 596k 3.35
2025-03-31 $3.1M 740k 4.23

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Cumberland Pharmaceuticals

Millennium Management
Ikarian Capital
Renaissance Technologies
Vanguard Group
Dimensional Fund Advisors
J. Goldman & Co
Bridgeway Capital Management
Boothbay Fund Management
Geode Capital Management
Citadel Advisors
Bank of New York Mellon
BlackRock
Acadian Asset Management
Two Sigma Investments
State Street Corporation

View all funds holding Cumberland Pharmaceuticals